ARCHIVES

SEC Investigating Bristol-Myers’ Sales Statements

This article is from The Cancer Letter archive.

Vol. 28 No. 28 | July 12, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974

NCI to Get 43 Out Of 200 New Aids Positions, 15 Others; Roper Says That’s “Fair”

November 11, 1988

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

Moses To Lead AACI.

October 19, 2001

Congress Deluged With Protests From Biomedical Researchers Over Grants Reduction, Budget Cuts

February 15, 1985

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000